CONSEGNA 30/70 INJ 3ML is used for the treatment of both type 1 and type 2 diabetes mellitus. Diabetes mellitus is a condition that affects the way the body processes glucose. In Diabetes Mellitus Type 1, the body does not make enough insulin to control blood sugar levels. In Diabetes Mellitus type 2, either the body stops producing enough insulin (the hormone which helps to decrease sugar levels in the blood), or there is resistance to the action of insulin. As a result, insulin is produced in large amounts, but it cannot act on the organs of the body.

CONSEGNA 30/70 INJ 3ML is a combination of two drugs: Human insulin (a short-acting type of insulin) and Insulin isophane (intermediate-acting). CONSEGNA 30/70 INJ 3ML suppresses the production of sugar in the liver and facilitates the reuptake of sugar in the fat and muscle cells; thereby, CONSEGNA 30/70 INJ 3ML ensures rapid and consistent sugar control. 

Take CONSEGNA 30/70 INJ 3ML as advised by your doctor. If you are not well trained to self-administer CONSEGNA 30/70 INJ 3ML, ask your healthcare professional to administer it. In some cases, CONSEGNA 30/70 INJ 3ML may cause certain common side effects like an allergic reaction at the site of injection, hypoglycemia (low blood glucose level), itching, lipodystrophy (skin thickening or pits at the injection site), oedema (swelling), rashes, and weight gain. Most of these side effects of CONSEGNA 30/70 INJ 3ML do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Consult your doctor before taking CONSEGNA 30/70 INJ 3ML if you are pregnant or breastfeeding. CONSEGNA 30/70 INJ 3ML may cause drowsiness, so drive with caution. Avoid alcohol consumption along with CONSEGNA 30/70 INJ 3ML as it may cause unpleasant side effects. CONSEGNA 30/70 INJ 3ML should be given to children only if prescribed by the doctor. Keep your doctor informed about your health condition and medications to rule out any interactions. CONSEGNA 30/70 INJ 3ML is a cold chain medicine, it has to be stored in the refrigerator between 2-8°C else its efficiency may be lost. Do not store in the freezer.

CONSEGNA 30/70 INJ 3ML should be administered subcutaneously (in the upper thigh, abdomen, upper arm, or buttocks). It should never be administered intravenously or in the vein. If you are not well trained to self-administer CONSEGNA 30/70 INJ 3ML, ask your healthcare professional to administer it.

CONSEGNA 30/70 INJ 3ML is a combination of two drugs: Human insulin (a short-acting type of insulin) and Insulin isophane (intermediate-acting). CONSEGNA 30/70 INJ 3ML is used for the treatment of both type 1 and type 2 diabetes mellitus. CONSEGNA 30/70 INJ 3ML suppresses the production of sugar in the liver and facilitates the reuptake of sugar in the fat and muscle cells; thereby, CONSEGNA 30/70 INJ 3ML ensures rapid and consistent sugar control.  CONSEGNA 30/70 INJ 3ML helps in improving glycaemic control, which in turn decreases the risk of progression of diabetes complications like damage to the retina (retinopathy), damage to the kidney (nephropathy), damage of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer.

Do not take CONSEGNA 30/70 INJ 3ML if you are allergic to any of the contents. Inform your doctor if you have hypoglycemia (low blood glucose levels), hypokalemia (low levels of potassium in the blood), heart, kidney or liver problems. Consult a doctor before taking CONSEGNA 30/70 INJ 3ML if you are pregnant or breastfeeding. CONSEGNA 30/70 INJ 3ML may cause dizziness, so drive only if you are alert. You are recommended not to consume alcohol as it may cause unpleasant side effects. Care should be taken when you are travelling across more than 2 time zones; your doctor may adjust your insulin schedule.